Physician profile
Ian Pitha
NPI 1952560294
$84,674.34
in general payments reported to CMS, 2019-2025
6 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $21K · 2021: $17K · 2022: $2,329 · 2023: $1,100 · 2024: $11K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Long Term Medical Supply Or Device Loan: $1,039 · Food and Beverage: $747 · Travel and Lodging: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,887.50 |
| Long Term Medical Supply Or Device Loan | $1,038.75 |
| Food and Beverage | $747.34 |
| Travel and Lodging | $645.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $83,252.90 | 2019-2025 | Product In Development |
| Alcon Vision LLC | $1,073.08 | 2025 | Voyager Dslt, Hydrus Microstent |
| Abbvie INC. | $265.62 | 2024-2025 | |
| New World Medical,INC. | $69.28 | 2025 | Streamline, Clearpath, Via360 |
| Coopervision INC. | $13.46 | 2024 | Onefit Contact Lens |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Pitha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.